Patent 7638487 was granted and assigned to AGENNIX, INC. on December, 2009 by the United States Patent and Trademark Office.
The present invention relates to methods of using lactoferrin (LF) to reduce pain in conditions associated with severe or intractable pain by administering a composition of lactoferrin either alone or in combination with other therapy for pain.